Sean Maenpaa

Company: Telix Pharmaceuticals

Job title: Vice-President, Global Commercialization

Seminars:

Choice Of Molecule & Isotope For Theranostic Indications; Exploring The Telix Pipeline 12:30 pm

Look at latest developments in theranostics for prostate cancer How theranostics hold up for renal cancer Applying this therapeutic to under served glioblastoma treatment • Integrating into existing oncology pathwayRead more

day: Day One Track B AM